Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Michael et al, 1999, Canada | 289 Consecutive ED patients with a primary diagnosis of recent-onset AF | Retrospective cohort study | Discharge from ED. ED return rate after chemical cardioversion. ED return rate after electrical cardioversion. Thromboembolic event | 99% (160/161) of successfully cardioverted patients were discharged home from the ED. 12% ED return rate (11/89), 10 for relapse of AF and 1 for a new problem. 10% ED return rate (7/71): 6 for relapse of AF. None | Complication rate may be underestimated because the follow-up period was 7 days and limited to return visits to the study site |
Burton et al, 2004, USA | 388 Patients (mean age 61 years; range 20–93 years) who underwent ED electrical cardioversion in 4 institutions. Duration was less than 48 h in 99% of the cohort | Retrospective health records survey | Discharge from ED. Return to ED. Thromboembolic event | 333 (86%) Patients were discharged to home from the ED: 301 after electrical cardioversion success and 32 with electrical cardioversion failure. 39 Patients (10%) returned to the ED within 7 days, 25 of these patients (6% of successful electrical cardioversion patients) returned because of relapse of AF. None | Record survey only. Follow-up only done for 7 days |
Jacoby et al, 2005, USA | Patients were eligible for study inclusion, they presented to the ED with recent-onset AF/flutter or if they presented with AF/flutter of an unknown duration but received therapeutic anticoagulation. 24 Patients were included in the study and 30 ED cardioversions were performed on 24 enrolled patients (average age 63 years; 63% men; 37% receiving warfarin). The presenting rhythm was AF in 87% of patients and atrial flutter in 13% | Prospective cohort study with a retrospective control group conducted at a community teaching hospital in the USA. Outcomes of ED electrocardioversion of patients with recent-onset AF/flutter were compared with those of a control group, obtained by chart review of patients admitted with the same inclusion criteria during the 1-year study period | Discharge from ED. Adverse event including thromboembolic event. Relapse rate | 18 Of the 24 patients were discharged home from the ED after cardioversion. None. Five patients reported a relapse of their dysrhythmia | Small sample size, which is based on convenience sampling. Discharge rate not very high |
Lo et al, 2006, Australia | All patients with acute AF who received biphasic cardioversion were enrolled. Acute AF was defined as AF in which symptoms had been present for less than 48 h | A prospective, descriptive study at a tertiary hospital ED over a 6-month period. Data collected included: patient demographics, past medical history, details of biphasic cardioversion, outcome, complications, disposition, and length of stay | Discharge from ED after cardioversion. Relapse rate at 3 months follow-up. Thromboembolic event | 26 Out of 31(83.8%) were discharged after successful cardioversion. Seven patients out of 32 (22%) had recurrence. None | Sample size was small. No formal protocol describing the decision-making process, hence there may be a selection bias. Risk of interviewer bias at follow-up |
Scheuermeyer et al, 2010, UK | 400 Patients who underwent direct-current cardioversion | Retrospective cohort study | Discharge home from ED. Return visits. Adverse events (death or thromboembolic) over 30 days follow-up | Of the 141 patients included in the chart review, 96.5% (136/141) were discharged after cardioversion. A total of 22 return visits occurred, of which 12 (3%; 12/400) were related to AF/flutter. None (95% CI 0.0 to 0.8% for all outcomes) | Results of this two-centre study may not be generalisable to diverse settings. Retrospective studies are subject to missing or improperly coded data. The duration of AF or flutter is based on self-reported patient histories and may not be accurate |
Stiell et al, 2010, Canada | 660 Patients (average age 65 years) with recent-onset AF (628) or flutter (32) presenting to an adult university hospital ED | Retrospective cohort study | Discharge from ED. Relapse rate. Adverse events rate. Thromboembolic event or death | 97% (639/660) Patients were discharged home of whom 90% (595/660) were in sinus rhythm. 8.6% (57/660) Over 7 days. 7.6% (50/660) Of which transient hypotension (6.7%; 44/660) was the commonest. None | The follow-up period was limited to 7 days, so adverse events occurring beyond this period would have been missed |
Vinson et al, 2012, USA | 206 Patients (aged 64.0 ± 14.4 years) presenting to three community-based hospitals with presumed recent-onset AF (92.7%) or flutter | Prospective cohort study among three neighbouring suburban | Overall discharge rate. Discharge rate in those cardioverted. ED adverse events due to attempted cardioversion. Thromboembolic events within 30 days | 88.8% (183/206). 91% (105/115). 2.6% (4/115). 1% (2/206) (95% CI 0.1 to 3.5%). Both cases involved cerebrovascular accidents. Both patients had a previous history of AF and were not receiving anticoagulation at the time of the thromboembolic event, one due to previous haemorrhagic complications and the other due to persistent refusal | Patient enrolment employed convenience sampling which may lead to potential selection bias. The number of patients with recent-onset AF or flutter who were not included in the study is not known. Data about practice patterns may not be generalisable to other settings and patient populations |